Examining COVID's Lasting Effects in Psychiatry

<p>In this episode, we delve into the intriguing world of COVID-19's long-term effects in psychiatry. We explore a groundbreaking study that examines the duration of COVID-associated psychiatric disorders and variations in susceptibility by age. How long do these disorders persist, and are certain age groups more affected?</p> <p>Faculty: Jim Phelps, M.D.<br /> Host: Richard Seeber, M.D.</p> <ul> <li style="font-weight: bold;"><a href= "https://psychopharmacologyinstitute.com/cme-program?section=pricing&utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC241" target="_blank" rel="noopener"><strong>Learn more about our membership here</strong></a></li> <li style="font-weight: bold;"><a href= "https://psychopharmacologyinstitute.com/publication/quick-take-vol-46-2693?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC241" target="_blank" rel="noopener"><strong>Earn 0.5 CMEs: Quick Take Vol. 46</strong></a></li> <li style="font-weight: bold;"><a href= "https://psychopharmacologyinstitute.com/section/neurologic-and-psychiatric-risk-trajectories-after-sars-cov-2-infection-an-analysis-of-2-year-retrospective-cohort-studies-including-1284437-patients-2693-5367?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC241" target="_blank" rel="noopener"><strong>Neurologic and Psychiatric Risk Trajectories After SARS-CoV-2 Infection: An Analysis of 2-Year Retrospective Cohort Studies Including 1,284,437 Patients</strong></a></li> </ul>